Identity, purity, potency, net content — what each line on a COA actually proves, walked through on a real report, and the gaps a clean-looking document can still hide.
A purity percentage and a fill weight are different facts. This lot is 99.7% pure and holds 12.6 mg where the label says 10 — read only the first and you would never know the second.
Peer-reviewed studies and preclinical-to-clinical translation, read with a skeptical eye.
Preclinical data is where most of the excitement in the peptide world originates — and where most of it should be tempered. A field guide to reading animal studies with the skepticism they deserve.
How peptides are analyzed, what a COA proves, and where clean-looking reports still mislead.
FDA guidance, warning letters, and what "research use only" does and does not mean.
In a single day, the FDA told multiple peptide sellers that an RUO label does not control when the surrounding evidence establishes an intended human-drug use. The reasoning is worth reading closely.
Registered trial status, phases, and published data — reported as data, not recommendation.
Purity and net content answer different questions. Conflating them is the single most common way a technically honest COA leaves a buyer worse off.
Preclinical data is where most of the excitement in the peptide world originates — and where most of it should be tempered. A field guide to reading animal studies with the skepticism they deserve.
In a single day, the FDA told multiple peptide sellers that an RUO label does not control when the surrounding evidence establishes an intended human-drug use. The reasoning is worth reading closely.
ClinicalTrials.gov is public, free, and the fastest way to separate a compound with real human data behind it from one riding on preclinical hype. Here's how to read a record.
A weekly digest of peptide research, testing, clinical trials, and regulatory developments. No dosing advice. No product pitches.